Nat Rev Cardiol 20:463474
Therefore, GLP-1 receptor agonists should not be prescribed as isolated weight-loss agents in KOA patients, but should be embedded within a monitored care plan that includes nutritional assessment, hydration advice, and follow-up of tolerability
In addition, peptide polyagonists (i.e., synthetic molecules that combine the amino acid sequences of more than one peptide, thus having the ability to bind to more than one receptor), such as tirzepatide (LY3298176) [a dual GLP-1RA and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist] have also been introduced into the management of metabolic diseases, including T2DM and obesity, and also are under investigation for NAFLD with high expectations [7]
Our mission is to help you achieve radiant, healthy skin that reflects your inner confidence.
A meta-analysis of randomized controlled trials showed that use of antibiotics for acute rhinosinusitis offers a small therapeutic benefit over placebo, with a corresponding rise in the risk for adverse events.5 Reactive Oxygen Species (ROS) are produced under physiological conditions and their production and antioxidant activity are balanced
Which peptide is more relevant for obesity research